Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 237

1.

Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease.

Goel G, Tye-Din JA, Qiao SW, Russell AK, Mayassi T, Ciszewski C, Sarna VK, Wang S, Goldstein KE, Dzuris JL, Williams LJ, Xavier RJ, Lundin KEA, Jabri B, Sollid LM, Anderson RP.

Sci Adv. 2019 Aug 7;5(8):eaaw7756. doi: 10.1126/sciadv.aaw7756. eCollection 2019 Aug.

2.

A system for students' evaluation of lectures in the medical programme in Oslo.

Stokke S, Solberg IL, Grøttum P, Lundin KEA, Heggen KM, Breivik J.

Tidsskr Nor Laegeforen. 2019 Aug 15;139(11). doi: 10.4045/tidsskr.19.0027. Print 2019 Aug 20. Norwegian, English.

3.

Chemical Development of Therapeutic Oligonucleotides.

Lundin KE, Gissberg O, Smith CIE, Zain R.

Methods Mol Biol. 2019;2036:3-16. doi: 10.1007/978-1-4939-9670-4_1.

PMID:
31410788
4.

No major reduction in bone mineral density after long-term treatment of patients with Celiac Disease.

Hære P, Høie O, Lundin KEA, Haugeberg G.

Eur J Intern Med. 2019 Oct;68:23-29. doi: 10.1016/j.ejim.2019.07.024. Epub 2019 Aug 8.

PMID:
31401019
5.

Efficient T cell-B cell collaboration guides autoantibody epitope bias and onset of celiac disease.

Iversen R, Roy B, Stamnaes J, Høydahl LS, Hnida K, Neumann RS, Korponay-Szabó IR, Lundin KEA, Sollid LM.

Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15134-15139. doi: 10.1073/pnas.1901561116. Epub 2019 Jul 8.

PMID:
31285344
6.

European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders.

Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders DS, Cellier C, Mulder CJ, Lundin KEA.

United European Gastroenterol J. 2019 Jun;7(5):583-613. doi: 10.1177/2050640619844125. Epub 2019 Apr 13. Review.

7.

Dietary and symptom assessment in adults with self-reported non-coeliac gluten sensitivity.

Skodje GI, Minelle IH, Rolfsen KL, Iacovou M, Lundin KEA, Veierød MB, Henriksen C.

Clin Nutr ESPEN. 2019 Jun;31:88-94. doi: 10.1016/j.clnesp.2019.02.012. Epub 2019 Mar 11.

PMID:
31060839
8.

Oligonucleotide⁻Palladacycle Conjugates as Splice-Correcting Agents.

Hande M, Saher O, Lundin KE, Smith CIE, Zain R, Lönnberg T.

Molecules. 2019 Mar 26;24(6). pii: E1180. doi: 10.3390/molecules24061180.

9.

Distinct phenotype of CD4+ T cells driving celiac disease identified in multiple autoimmune conditions.

Christophersen A, Lund EG, Snir O, Solà E, Kanduri C, Dahal-Koirala S, Zühlke S, Molberg Ø, Utz PJ, Rohani-Pichavant M, Simard JF, Dekker CL, Lundin KEA, Sollid LM, Davis MM.

Nat Med. 2019 May;25(5):734-737. doi: 10.1038/s41591-019-0403-9. Epub 2019 Mar 25.

10.

Oligonucleotide Binding to Non-B-DNA in MYC.

Umek T, Sollander K, Bergquist H, Wengel J, Lundin KE, Smith CIE, Zain R.

Molecules. 2019 Mar 12;24(5). pii: E1000. doi: 10.3390/molecules24051000.

11.

Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial.

Goll GL, Jørgensen KK, Sexton J, Olsen IC, Bolstad N, Haavardsholm EA, Lundin KEA, Tveit KS, Lorentzen M, Berset IP, Fevang BTS, Kalstad S, Ryggen K, Warren DJ, Klaasen RA, Asak Ø, Baigh S, Blomgren IM, Brenna Ø, Bruun TJ, Dvergsnes K, Frigstad SO, Hansen IM, Hatten ISH, Huppertz-Hauss G, Henriksen M, Hoie SS, Krogh J, Midtgard IP, Mielnik P, Moum B, Noraberg G, Poyan A, Prestegård U, Rashid HU, Strand EK, Skjetne K, Seeberg KA, Torp R, Ystrøm CM, Vold C, Zettel CC, Waksvik K, Gulbrandsen B, Hagfors J, Mørk C, Jahnsen J, Kvien TK.

J Intern Med. 2019 Jun;285(6):653-669. doi: 10.1111/joim.12880. Epub 2019 Apr 12.

PMID:
30762274
12.

Enterovirus as trigger of coeliac disease: nested case-control study within prospective birth cohort.

Kahrs CR, Chuda K, Tapia G, Stene LC, Mårild K, Rasmussen T, Rønningen KS, Lundin KEA, Kramna L, Cinek O, Størdal K.

BMJ. 2019 Feb 13;364:l231. doi: 10.1136/bmj.l231.

13.

The ability of locked nucleic acid oligonucleotides to pre-structure the double helix: A molecular simulation and binding study.

Xu Y, Gissberg O, Pabon-Martinez YV, Wengel J, Lundin KE, Smith CIE, Zain R, Nilsson L, Villa A.

PLoS One. 2019 Feb 12;14(2):e0211651. doi: 10.1371/journal.pone.0211651. eCollection 2019.

14.

Mosaic deletion patterns of the human antibody heavy chain gene locus shown by Bayesian haplotyping.

Gidoni M, Snir O, Peres A, Polak P, Lindeman I, Mikocziova I, Sarna VK, Lundin KEA, Clouser C, Vigneault F, Collins AM, Sollid LM, Yaari G.

Nat Commun. 2019 Feb 7;10(1):628. doi: 10.1038/s41467-019-08489-3.

15.

Coeliac disease.

Lindfors K, Ciacci C, Kurppa K, Lundin KEA, Makharia GK, Mearin ML, Murray JA, Verdu EF, Kaukinen K.

Nat Rev Dis Primers. 2019 Jan 10;5(1):3. doi: 10.1038/s41572-018-0054-z. Review.

PMID:
30631077
16.

Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.

Høydahl LS, Richter L, Frick R, Snir O, Gunnarsen KS, Landsverk OJB, Iversen R, Jeliazkov JR, Gray JJ, Bergseng E, Foss S, Qiao SW, Lundin KEA, Jahnsen J, Jahnsen FL, Sandlie I, Sollid LM, Løset GÅ.

Gastroenterology. 2019 Apr;156(5):1428-1439.e10. doi: 10.1053/j.gastro.2018.12.013. Epub 2018 Dec 26.

PMID:
30593798
17.

Discriminative T-cell receptor recognition of highly homologous HLA-DQ2-bound gluten epitopes.

Dahal-Koirala S, Ciacchi L, Petersen J, Risnes LF, Neumann RS, Christophersen A, Lundin KEA, Reid HH, Qiao SW, Rossjohn J, Sollid LM.

J Biol Chem. 2019 Jan 18;294(3):941-952. doi: 10.1074/jbc.RA118.005736. Epub 2018 Nov 19.

PMID:
30455354
18.

Fatigue as an Extra-Intestinal Manifestation of Celiac Disease: A Systematic Review.

Jelsness-Jørgensen LP, Bernklev T, Lundin KEA.

Nutrients. 2018 Nov 3;10(11). pii: E1652. doi: 10.3390/nu10111652.

19.

Effects of individualized nutrition after allogeneic hematopoietic stem cell transplantation following myeloablative conditioning; a randomized controlled trial.

Skaarud KJ, Hjermstad MJ, Bye A, Veierød MB, Gudmundstuen AM, Lundin KEA, Distante S, Brinch L, Tjønnfjord GE, Iversen PO.

Clin Nutr ESPEN. 2018 Dec;28:59-66. doi: 10.1016/j.clnesp.2018.08.002. Epub 2018 Aug 29.

PMID:
30390894
20.

Positive IgA against transglutaminase 2 in patients with distal radius and ankle fractures compared to community-based controls.

Hjelle AM, Apalset E, Mielnik P, Nilsen RM, Lundin KEA, Tell GS.

Scand J Gastroenterol. 2018 Oct - Nov;53(10-11):1212-1216. doi: 10.1080/00365521.2018.1509122. Epub 2018 Sep 28.

PMID:
30265163
21.

Novel peptide-dendrimer/lipid/oligonucleotide ternary complexes for efficient cellular uptake and improved splice-switching activity.

Saher O, Rocha CSJ, Zaghloul EM, Wiklander OPB, Zamolo S, Heitz M, Ezzat K, Gupta D, Reymond JL, Zain R, Hollfelder F, Darbre T, Lundin KE, El Andaloussi S, Smith CIE.

Eur J Pharm Biopharm. 2018 Nov;132:29-40. doi: 10.1016/j.ejpb.2018.09.002. Epub 2018 Sep 4.

PMID:
30193928
22.

Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report.

Lundin KE, Wang Q, Hamasy A, Marits P, Uzunel M, Wirta V, Wikström AC, Fasth A, Ekwall O, Smith CIE.

BMC Pediatr. 2018 Aug 29;18(1):285. doi: 10.1186/s12887-018-1258-9.

23.

Transcriptional profiling reveals monocyte-related macrophages phenotypically resembling DC in human intestine.

Richter L, Landsverk OJB, Atlasy N, Bujko A, Yaqub S, Horneland R, Øyen O, Aandahl EM, Lundin KEA, Stunnenberg HG, Bækkevold ES, Jahnsen FL.

Mucosal Immunol. 2018 Sep;11(5):1512-1523. doi: 10.1038/s41385-018-0060-1. Epub 2018 Jul 23.

PMID:
30038215
24.

Reply.

Skodje GI, Henriksen C, Veierød MB, Gibson PR, Lundin KEA.

Gastroenterology. 2018 Jul;155(1):228. doi: 10.1053/j.gastro.2018.06.032. Epub 2018 Jun 9. No abstract available.

PMID:
29894682
25.

Is Non-Celiac Rice-Starch Sensitivity as Common in Children as Non-Celiac Gluten Sensitivity?

Gibson PR, Lundin KEA, Guandalini S.

Am J Gastroenterol. 2018 Aug;113(8):1254. doi: 10.1038/s41395-018-0079-7. Epub 2018 Jun 8. No abstract available.

PMID:
29880973
26.

Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease.

Risnes LF, Christophersen A, Dahal-Koirala S, Neumann RS, Sandve GK, Sarna VK, Lundin KE, Qiao SW, Sollid LM.

J Clin Invest. 2018 Jun 1;128(6):2642-2650. doi: 10.1172/JCI98819. Epub 2018 May 14.

27.

Characterization of the Small Intestinal Lesion in Celiac Disease by Label-Free Quantitative Mass Spectrometry.

Tutturen AEV, Dørum S, Clancy T, Reims HM, Christophersen A, Lundin KEA, Sollid LM, de Souza GA, Stamnaes J.

Am J Pathol. 2018 Jul;188(7):1563-1579. doi: 10.1016/j.ajpath.2018.03.017. Epub 2018 Apr 22.

PMID:
29684362
28.

Subtherapeutic concentrations of infliximab and adalimumab are associated with increased disease activity in Crohn's disease.

Carlsen A, Omdal R, Leitao KØ, Isaksen K, Hetta AK, Karlsen LN, Aabakken L, Bolstad N, Warren D, Lundin KEA, Grimstad T.

Therap Adv Gastroenterol. 2018 Mar 14;11:1756284818759930. doi: 10.1177/1756284818759930. eCollection 2018.

29.

Outcome measures in coeliac disease trials: the Tampere recommendations.

Ludvigsson JF, Ciacci C, Green PH, Kaukinen K, Korponay-Szabo IR, Kurppa K, Murray JA, Lundin KEA, Maki MJ, Popp A, Reilly NR, Rodriguez-Herrera A, Sanders DS, Schuppan D, Sleet S, Taavela J, Voorhees K, Walker MM, Leffler DA.

Gut. 2018 Aug;67(8):1410-1424. doi: 10.1136/gutjnl-2017-314853. Epub 2018 Feb 13.

30.

TNFα-Inhibitors in Inflammatory Bowel Disease [Internet].

Ringerike T, Elvsaas IKØ, Coll P, Lundin KEA, Movik E, Gjertsen MK.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2008 Dec.

31.

Efficacy of infliximab biosimilars in patients with Crohn's disease - Authors' reply.

Jørgensen KK, Lundin KE, Olsen IC, Kvien TK, Jahnsen J.

Lancet. 2017 Dec 2;390(10111):2436. doi: 10.1016/S0140-6736(17)32463-7. Epub 2017 Dec 1. No abstract available.

PMID:
29208304
32.

HLA-DQ-Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption.

Sarna VK, Lundin KEA, Mørkrid L, Qiao SW, Sollid LM, Christophersen A.

Gastroenterology. 2018 Mar;154(4):886-896.e6. doi: 10.1053/j.gastro.2017.11.006. Epub 2017 Nov 14.

PMID:
29146521
33.

Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity.

Skodje GI, Sarna VK, Minelle IH, Rolfsen KL, Muir JG, Gibson PR, Veierød MB, Henriksen C, Lundin KEA.

Gastroenterology. 2018 Feb;154(3):529-539.e2. doi: 10.1053/j.gastro.2017.10.040. Epub 2017 Nov 2.

PMID:
29102613
34.

Electives in the medical degree programme.

Frich JC, Breivik J, Lundin KEA, Rosvold EO, Os I.

Tidsskr Nor Laegeforen. 2017 Oct 30;137(20). doi: 10.4045/tidsskr.17.0549. Print 2017 Oct 31. Norwegian, English. No abstract available.

35.

Linking Spatial Structure and Community-Level Biotic Interactions through Cooccurrence and Time Series Modeling of the Human Intestinal Microbiota.

de Muinck EJ, Lundin KEA, Trosvik P.

mSystems. 2017 Sep 5;2(5). pii: e00086-17. doi: 10.1128/mSystems.00086-17. eCollection 2017 Sep-Oct.

36.

LNA effects on DNA binding and conformation: from single strand to duplex and triplex structures.

Pabon-Martinez YV, Xu Y, Villa A, Lundin KE, Geny S, Nguyen CH, Pedersen EB, Jørgensen PT, Wengel J, Nilsson L, Smith CIE, Zain R.

Sci Rep. 2017 Sep 8;7(1):11043. doi: 10.1038/s41598-017-09147-8.

37.

Stereotyped antibody responses target posttranslationally modified gluten in celiac disease.

Snir O, Chen X, Gidoni M, du Pré MF, Zhao Y, Steinsbø Ø, Lundin KE, Yaari G, Sollid LM.

JCI Insight. 2017 Sep 7;2(17). pii: 93961. doi: 10.1172/jci.insight.93961. eCollection 2017 Sep 7.

38.

A TCRα framework-centered codon shapes a biased T cell repertoire through direct MHC and CDR3β interactions.

Gunnarsen KS, Høydahl LS, Risnes LF, Dahal-Koirala S, Neumann RS, Bergseng E, Frigstad T, Frick R, du Pré MF, Dalhus B, Lundin KE, Qiao SW, Sollid LM, Sandlie I, Løset GÅ.

JCI Insight. 2017 Sep 7;2(17). pii: 95193. doi: 10.1172/jci.insight.95193. eCollection 2017 Sep 7.

39.

Strong Clonal Relatedness between Serum and Gut IgA despite Different Plasma Cell Origins.

Iversen R, Snir O, Stensland M, Kroll JE, Steinsbø Ø, Korponay-Szabó IR, Lundin KEA, de Souza GA, Sollid LM.

Cell Rep. 2017 Sep 5;20(10):2357-2367. doi: 10.1016/j.celrep.2017.08.036.

40.

HLA-DQ:gluten tetramer test in blood gives better detection of coeliac patients than biopsy after 14-day gluten challenge.

Sarna VK, Skodje GI, Reims HM, Risnes LF, Dahal-Koirala S, Sollid LM, Lundin KEA.

Gut. 2018 Sep;67(9):1606-1613. doi: 10.1136/gutjnl-2017-314461. Epub 2017 Aug 4.

PMID:
28779027
41.

Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses.

Stenler S, Lundin KE, Hansen L, Petkov S, Mozafari N, Isaguliants M, Blomberg P, Smith CIE, Goldenberg DM, Chang CH, Ljungberg K, Hinkula J, Wahren B.

Hum Vaccin Immunother. 2017 Dec 2;13(12):2849-2858. doi: 10.1080/21645515.2017.1338546. Epub 2017 Jul 11.

42.

Early growth in children with coeliac disease: a cohort study.

Kahrs CR, Magnus MC, Stigum H, Lundin KEA, Størdal K.

Arch Dis Child. 2017 Nov;102(11):1037-1043. doi: 10.1136/archdischild-2016-312304. Epub 2017 Jun 13.

PMID:
28611068
43.

High-Throughput Single-Cell Analysis of B Cell Receptor Usage among Autoantigen-Specific Plasma Cells in Celiac Disease.

Roy B, Neumann RS, Snir O, Iversen R, Sandve GK, Lundin KEA, Sollid LM.

J Immunol. 2017 Jul 15;199(2):782-791. doi: 10.4049/jimmunol.1700169. Epub 2017 Jun 9.

44.

Role of Pseudoisocytidine Tautomerization in Triplex-Forming Oligonucleotides: In Silico and in Vitro Studies.

Hartono YD, Pabon-Martinez YV, Uyar A, Wengel J, Lundin KE, Zain R, Smith CIE, Nilsson L, Villa A.

ACS Omega. 2017 May 31;2(5):2165-2177. doi: 10.1021/acsomega.7b00347. Epub 2017 May 17.

45.

Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial.

Jørgensen KK, Olsen IC, Goll GL, Lorentzen M, Bolstad N, Haavardsholm EA, Lundin KEA, Mørk C, Jahnsen J, Kvien TK; NOR-SWITCH study group.

Lancet. 2017 Jun 10;389(10086):2304-2316. doi: 10.1016/S0140-6736(17)30068-5. Epub 2017 May 11. Erratum in: Lancet. 2017 Jun 10;389(10086):2286.

PMID:
28502609
46.

CTG repeat-targeting oligonucleotides for down-regulating Huntingtin expression.

Zaghloul EM, Gissberg O, Moreno PMD, Siggens L, Hällbrink M, Jørgensen AS, Ekwall K, Zain R, Wengel J, Lundin KE, Smith CIE.

Nucleic Acids Res. 2017 May 19;45(9):5153-5169. doi: 10.1093/nar/gkx111.

47.

Non-coeliac gluten sensitivity.

Gibson PR, Skodje GI, Lundin KE.

J Gastroenterol Hepatol. 2017 Mar;32 Suppl 1:86-89. doi: 10.1111/jgh.13705. Review.

PMID:
28244667
48.

CVID and Celiac Disease.

Jørgensen SF, Reims HM, Aukrust P, Lundin KE, Fevang B.

Am J Gastroenterol. 2017 Feb;112(2):393. doi: 10.1038/ajg.2016.551. No abstract available.

PMID:
28154406
49.

Wheat challenge in self-reported gluten sensitivity: a comparison of scoring methods.

Skodje GI, Henriksen C, Salte T, Drivenes T, Toleikyte I, Lovik AM, Veierød MB, Lundin KE.

Scand J Gastroenterol. 2017 Feb;52(2):185-192. doi: 10.1080/00365521.2016.1244705. Epub 2016 Oct 31.

PMID:
27797273
50.

Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease.

Fløisand Y, Lundin KEA, Lazarevic V, Kristiansen JD, Osnes LTN, Tjønnfjord GE, Reims HM, Gedde-Dahl T.

Biol Blood Marrow Transplant. 2017 Jan;23(1):172-175. doi: 10.1016/j.bbmt.2016.10.009. Epub 2016 Oct 21.

Supplemental Content

Loading ...
Support Center